Adamis Pharmaceuticals Corpora
Description Adamis Pharmaceuticals Corporation, a biopharmaceutical company, engages in the development and commercialization of specialty pharmaceutical products in the therapeutic areas of oncology, immunology and infectious diseases, and allergy and respiratory. The companys allergy and respiratory product candidates include Epinephrine Injection PFS, a pre-filled epinephrine syringe for the treatment of anaphylaxis; APC-3000, a HFA inhaled nasal steroid product for the treatment of seasonal and perennial allergic rhinitis; and metered dose inhaler products, such as APC-1000 and APC-2000 for the treatment of asthma and chronic obstructive pulmonary disease. Its products under development also comprise Savvy/C31G, a contraceptive gel; and TeloB-VAX, a novel cell-based therapeutic cancer vaccine. In addition, the company is developing small molecule anti-inflammatory drugs, such as APC-100, APC-200, and APC-300 for the treatment of prostate cancer and inflammation. Adamis Pharmaceuticals Corporation has strategic agreement with Beximco Pharmaceuticals Ltd. The company is based in San Diego, California. To view the detailed information, you need to SUBSCRIBE with us. |
 |